Abstract
All animal cells share a common need for cholesterol which they obtain either by endogenous synthesis or by assimilation from the diet. The steroid nucleus plays both structural and metabolic roles. In cell membranes it is considered to act as a regulator of the micro-environment, maintaining a fluidity appropriate to the normal operation of membrane-linked enzyme systems and transport proteins. In specialized tissues such as the adrenal, gonad and liver it undergoes a variety of oxidation steps which increase its polarity and permit its direct transit through the aqueous fluids of the body. The parent sterol molecule lacks this facility and must therefore be solubilized by interaction with a number of amphipathic agents. In plasma it exists in association with phospholipid and certain proteins to form the lipid—protein complexes that we call lipoproteins. In bile, on the other hand, bile salts and phospholipid act as its emulsifying agents, leading to the production of micellar aggregates. These two transport systems are subject to interdependent regulation in the liver (Shepherd and Packard, 1987). Disturbances of either lead to pathological sequelae which result in deposition of the sterol in unusual sites like the gallbladder and the intima of artery walls. Such deposits are highly resistant to mobilization and further accretion leads to the macroscopic lesions which we recognize as gallstones and atherosclerotic plaques.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albers, J.J., Tollefson, J.H., Chen, C.H. and Steinmetz, A. (1984) Isolation and characterisation of human plasma lipid transfer proteins. Arteriosclerosis, 4, 49–58.
Anggard, E., Land, J.M., Lenihan, C.J., et al. (1986) Prevention of cardiovascular disease in general practice: a proposed model. Br. Med. J., 293, 177–80.
Balasubramaniam, S., Mitropolous, K.A. and Myant, N.B. (1973) Evidence for the compartmentalisation of cholesterol in rat liver microsomes. Eur. J. Biochem., 34, 77–83.
Barbaras, R., Puchois, P., Fruchart, J.C., et al. (1990) Purification of an apolipoprotein A binding protein from mouse adipose cells. Biochem. J., 269, 767–73.
Beisiegel, V., Weber, W., Ihrke, G., et al. (1989) The LDL receptor related protein, LRP, is an apolipoprotein E binding protein, Nature, 341, 162–7.
Beltz, W.F., Young, S.G. and Witztum, J.L. (1987) Heterogeneity in low density lipoprotein metabolism, in Proceedings of the Workshop on Lipoprotein Heterogeneity (ed. K. Lippel), NIH Publications No. 87–2646, Bethesda, USA, pp. 215–36.
Bilheimer, D.W., Grundy, S.M., Brown, M.S. and Goldstein, J.L. (1983) Mevinolin and colestipol stimulate receptor mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc. Natl Acad. Sci. USA, 80, 4124–8.
Blankenhorn, D.H., Nessini, S.A., Johnson, R.L., et al. (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA, 257, 3233–40.
Blum, C.B., Levy, R.I., Eisenberg, S., et al. (1977) High density lipoprotein metabolism in man. J. Clin. Invest., 60, 795–807.
Breckenridge, W.C., Little, J.A., Steiner, G., et al. (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein CII. N. Engl, J. Med., 298, 1265–70.
Brown, M.S. and Goldstein, J.L. (1983) Lipoprotein metabolism in the macrophage. Implications for cholesterol deposition in atherosclerosis. Ann. Rev. Biochem., 52, 223–61.
Cortese, C., Levy, Y., Janus, E.D., et al. (1983) Modes of action of lipid lowering diets in man: studies of apolipoprotein B kinetics in relation to fat consumption and dietary fat composition. Eur. J. Clin. Invest., 13, 79–85.
Dietschy, J.M. (1984) Regulation of cholesterol metabolism in man and in other species. Klin. Wochenschr., 62, 338–45.
Eisenberg, S., Gavish, D., Oschry, Y., et al. (1984) Abnormalities in very low, low and high density lipoproteins in hypertriglyceridaemia. Reversal toward normal with bezafibrate treatment. J. Clin. Invest., 74, 470–82.
Fagiotto, A., Ross, R. and Harker, L. (1984) Studies of hypercholesterolemia in the non-human primate. I. Changes that lead to fatty streak formation. Arteriosclerosis, 4, 323–40.
Fielding, C.J. and Fielding, P.E. (1981) Regulation of human plasma lecithin: cholesteryl acyl transferase activity by lipoprotein acceptor cholesteryl ester content. J. Biol. Chem., 256, 2102–4.
Goldstein, J.L. and Brown, M.S. (1977) The low density lipoprotein pathway and its relation to atherosclerosis. Ann. Rev. Biochem., 46, 897–930.
Goldstein, J.L. and Brown, M.S. (1989) Familial hypercholesterolemia, in The Metabolic Basis of Inherited Disease (eds C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle), McGraw Hill, New York, pp. 1215–50.
Goldstein, J.L., Ho, Y.K., Basu, J.K. and Brown, M.S. (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesteryl ester deposition. Proc. Natl Acad. Sci. USA, 76, 333–7.
Griffin, B.A., Caslake, M.J., Yip, B., et al. (1990) Rapid isolation of LDL subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis, 83, 59–67.
Havel, R.J., Goldstein, J.L. and Brown, M.S. (1980) Lipoproteins and lipid transport, in Metabolic Control and Disease (eds P.R. Bondy and L.E. Rosenberg), W.B. Saunders, Philadelphia, pp. 393–494.
Henricksen, T., Mahoney, E.M. and Steinberg, D. (1983) Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis, 3, 149–59.
Houlston, R., Quiney, J., Mount, J., et al. (1988) Lipoprotein(a) and coronary heart disease in familial hypercholesterolaemia. Lancet, ii, 405.
Karlin, J.B., Johnson, W.J., Benedict, C.R., et al. (1987) Cholesterol flux between cells and high density lipoprotein. J. Biol. Chem., 262, 12557–64.
Kesaniemi, Y.A. and Grundy, S.M. (1984) Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Atherosclerosis, 4, 41–8.
Kondo, I., Berg, K., Drayna, D. and Lawn, R. (1989) DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet, 35, 49–56.
Kuusi, T., Saarinen, P. and Nikkila, E.A. (1980) Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis, 36, 589–93.
McLean, J.W., Tombinson, J.E. and Kuang, W.J. (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature, 300, 132–7.
Mahley, R.W., Hui, D.Y., Innerarity, T.L. and Weisgraber, K.H. (1981) Two independent lipoprotein receptors on hepatic membranes of dog, swine and man. J. Clin. Invest., 68, 1197–206.
Mann, J.L., Lewis, B., Shepherd, J., et al. (1988) Blood lipid concentrations and other risk factors: distribution, prevalence and detection. Br. Med. J., 296, 1702–6.
Miles, L.A., Fless, G.M., Levin, E.G., et al. (1989) A potential basis for the thrombotic risks associated with lipoprotein (a). Nature, 338, 301–3.
Nestel, P., Tada, N., Billington, T., et al. (1982) Changes in very low density lipoproteins with cholesterol loading in man. Metabolism, 31, 398–405.
Packard, C.J., McKinney, L., Carr, K. and Shepherd, J. (1983) Cholesterol feeding increases low density lipoprotein synthesis. J. Clin. Invest., 72, 45–51.
Packard, C.J. and Shepherd, J. (1982) The hepatobiliary axis and lipoprotein metabolism. J. Lipid Res., 23, 1081–98.
Packard, C.J. and Shepherd, J. (1983) Low density lipoprotein receptor pathway in man: its role in regulating plasma low density lipoprotein levels. Atheroscler. Revs, 11, 29–64.
Powell, L.M., Wallis, S.C., Pease, R.J., et al. (1987) A novel form of tissue specific RNA processing produces apolipoprotein B48 in intestine. Cell, 50, 831–8.
Quintao, E., Grundy, S.M. and Ahrens, E.H. (1971) Effects of dietary cholesterol on the regulation of total body cholesterol in man. J. Lipid Res., 12, 233–47.
Ross, R. (1981) Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis, 1, 293–311.
Rudel, L.L. and Parks, J.S. (1982) Different kinetic fates of apolipoproteins AI and AII from lymph chylomicra of non human primates. Effect of saturated versus polyunsaturated dietary fat. J. Lipid Res., 23, 410–21.
Schonfeld, G., Patsch, W., Rudel, L.L., et al. (1982) Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J. Clin. Invest., 62, 1072–80.
Shaper, A.G., Pocock, S.J., Walker, M., et al. (1985) Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J. Epidemiol. Community Health, 39, 197–209.
Shepherd, J., Bicker, S., Lorimer, A.R. and Packard, C.J. (1979) Receptor mediated low density lipoprotein catabolism in man. J. Lipid Res., 20, 999–1006.
Shepherd, J. and Packard, C.J. (1987) Lipid transport through the plasma: the metabolic basis of hyperlipidaemia. Ballieres Clinical Endocrinology and Metabolism, 1, 495–514.
Shepherd, J., Packard, C.J., Grundy, S.M., et al. (1980) Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J. Lipid Res., 21, 91–9.
Shepherd, J., Packard, C.J., Patsch, J.R., et al. (1978) Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein AI. J. Clin. Invest., 61, 1582–92.
Simpson, H.S., Williamson, C.M., Pringle, S., et al. (1989) Hypolipidemic drugs and chylomicron metabolism, in Intestinal Lipid and Lipoprotein Metabolism (eds E. Windier and H. Greten), W. Zuchschwerdt Verlag, Munich, 194–201.
Slack, J. (1969) Risks of ischaemic heart disease in familial hypercholesterolaemic states. Lancet, ii, 1380–2.
Slater, H.R., Packard, C.J. and Shepherd, J. (1982) Receptor-independent catabolism of low density lipoprotein: involvement of the reticuloendothelial system. J. Biol. Chem., 257, 307–10.
Starzl, T.E., Bahnson, H.T., Hardesty, R.L., et al. (1984) Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet, i, 1382–3.
Study Group, European Atherosclerosis Society (1987) Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur. Heart J., 8, 77–88.
Ueshima, H., Iida, M. and Shimamoto, T. (1982) Dietary intake and total serum cholesterol level: their relationship to different lifestyles in several Japanese populations. Circulation, 66, 519–26.
Utermann, G., Menzel, H.J., Kraft, H.G., et al. (1987) Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) — lipoprotein concentrations in plasma. J. Clin. Invest., 80, 458–65.
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Shepherd, J., Packard, C.J. (1992). Atherosclerosis in perspective: the pathophysiology of human cholesterol metabolism. In: Human Nutrition. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4495-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-4495-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-40310-1
Online ISBN: 978-1-4899-4495-5
eBook Packages: Springer Book Archive